Stakeholder Position Statement on the NICE Guideline for Depression in Adults
Total Page:16
File Type:pdf, Size:1020Kb
Stakeholder position statement on the NICE guideline for depression in adults Organisational signatories All-Party Parliamentary Group for Prescribed Drug Dependence: Rt Hon Sir Oliver Letwin MP, Chair Association for Dance Movement Psychotherapy UK (ADMP UK): Jackie Edwards, Chair Association for Family Therapy and Systemic Practice (AFT): Dr Reenee Singh, CEO Association for Psychoanalytic Psychotherapy in the NHS (APP): Andrew Soutter, Chair Association of Child Psychotherapists (ACP): Isobel Pick, Chair British Acupuncture Council: Robert Strange OBE, CEO British Association of Art Therapists (BAAT): Dr Val Huet (PhD), CEO British Association for Counselling and Psychotherapy (BACP): Dr Andrew Reeves, Chair British Association of Social Workers: Dr Ruth Allen, CEO British Psychoanalytic Council (BPC): Gary Fereday, CEO British Psychoanalytic Society (and Institute of Psychoanalysis): Catalina Bronstein, President British Psychological Society (BPS): Sarb Bajwa, CEO British Psychotherapy Foundation (BPF): Mike Owen, CEO Camden Psychotherapy Unit (CPU): Ora Dresner, CEO College of Mental Health Pharmacy (CMHP): Juliet Shepherd, President Council for Evidence-based Psychiatry (CEP): Dr James Davies, co-founder European Association for Psychotherapy (EAP): Charles Cassar, President European Association for Gestalt Therapy (EAGT): Beatrix Wimmer, President Interpersonal Psychotherapy UK (IPT-UK): Yvonne Hemmings, Chair Metanoia Institute: Professor Sheila Owen-Jones, CEO National Survivor User Network (NSUN): Sarah Yiannoullou, Managing Director Psychotherapy and Counselling Union (PCU): Richard Bagnall-Oakeley, Chair Psychotherapy Foundation: Dr Stephen Buller, Chair Relate: Aidan Jones, CEO Society for Psychotherapy Research UK (SPR UK): Dr Felicitas Rost (PhD), President South London and Maudsley NHS Foundation Trust (SLAM): Dr Matthew Patrick, CEO Tavistock and Portman NHS Foundation Trust: Paul Jenkins, CEO Tavistock Relationships: Andrew Balfour, CEO The Association of Clinical Psychologists UK (ACP-UK): Dr Che Rosebert The Association for Cognitive Analytic Therapy (ACAT): Dr Alison Jenaway, Chair The British Association of Dramatherapists (BADth), Madeline Andersen-Warren, Acting Chair The Mindfulness Initiative: Jamie Bristow, Director UK Association for Gestalt Practitioners (UKAGP): Dr Belinda Harris, Chair UK Association for Humanistic Psychology Practitioners (UKAHPP): John Fletcher, Chair UK Council for Psychotherapy (UKCP): Professor Sarah Niblock, CEO UK Person-Centred Experiential (UKPCE): Dr David Murphy, Convenor University of Essex (UoE): Dr Susan McPherson, Senior Lecturer, School of Health and Social Care Individual signatories Professor Sir Simon Wessely, Regius Chair of Psychiatry, King’s College London; President, Royal Society of Medicine; Past President, Royal College of Psychiatrists. Professor Clare Gerada, General Practitioner and Senior Partner Hurley Group; Medical Director, Practitioner Health Programme. Jennifer Edwards CBE FFPH, Past Chief Executive Mental Health Foundation Michael Barkham PhD, FBPsS; Professor of Clinical Psychology, University of Sheffield Sharon Beirne, UKCP registered Gestalt psychotherapist Vincent Beja, Research Committee of the European Association for Gestalt Therapy (EAGT) Jon Blend, MA, Adult & Child Psychotherapist Heather Bolton, Registered Psychotherapist (GPTI, UKCP) & Mindfulness Teacher (UK Network registered) Dr Javier Malda Castillo, BPS Chartered Clinical Psychologist, North West Borough NHS Foundation Trust Martin Capps, UKCP, MSc, SM GPTI, Gestalt Psychotherapist, Trainer and Supervisor Zoë Chouliara, Professor in Mental Health, Abertay University Richard Davis, Senior Lecturer counselling/psychotherapy, University of Central Lancashire Lesley Dougan, Senior Lecturer, MA Counselling and Psychotherapy, Practice School of Nursing and Allied Health, Liverpool John Moores University Vienna Duff, Gestalt Psychotherapist, UKCP, UKAGP Robert Elliott, PhD, Professor of Counselling, University of Strathclyde Vicky Eugenio, MA Gestalt Psychotherapy- UKCP; Gestalt Centre-London Ed Fellows, UKCP Gestalt Psychotherapist, EMDR, sensorimotor, MBCT & Senior Counsellor, PTSD and bereavement lead, Southwark IAPT Jane Dianne Flint, UKCP registered Gestalt Psychotherapist Dr Belinda Harris, Associate Professor, University of Nottingham, UKCP Registered Psychotherapist Catherine Hayes Mbacp (Senior Acc), Assistant Professor of Counselling, University of Nottingham Dr Michael Hengartner, Zurich University of Applied Sciences Dr Trish Hobman, Subject Director, Counselling, Coaching and Mentoring, School of Psychological and Social Sciences, York St John University Dr Jonathan Isserow, Head of Partnerships; Convenor, MA Art Psychotherapy, Dept of Psychology, University Of Roehampton Stephen Joseph, PhD, Professor of Health and Social Care University of Nottingham Prof Vicky Karkou, Professor of Arts and Wellbeing, Edge Hill University Christine Kennett, Teaching and Supervising Member, Gestalt Psychotherapy &Training Institute Prof Willem Kuyken, Professor of Mindfulness and Psychological Science, University of Oxford Patricia Hunt, President Elect of the European Association for Psychotherapy and International Officer of the UK Council for Psychotherapy. Michał Kostrzewski, Vice President of the PTPG Lynne Lacock, Senior Lecturer/Course Lead, School of Psychological and Social Sciences York St John University Prof Del Loewenthal, Emeritus Professor of Psychotherapy and Counselling, University of Roehampton Roderic London, BACP & UKCP Accredited Counsellor and Psychotherapist Renata Mizerska, EC Member and External Relations & NOGTs Officer of the EAGT, President of the PTPG Dr Susan Mizen, Devon Partnership NHS Trust; Chair Talking Therapies Task Force David Murphy, PhD, CPsychol, AFBPsS, Associate Professor, University of Nottingham Dr Susie Orbach, Consultant, The Balint Consultancy Dr Vanja Orlans, Director, Psychology Matters Ltd. Dr Peter Pearce, Faculty Head, Applied Social and Organisation Sciences, Metanoia Institute May 2019 2 Martin Pollecoff, Chair, UK Council for Psychotherapy Sue Price, PhD, Assistant Professor of Counselling, University of Nottingham Lynne Rigaud, Vice Chair of the Science and Research Committee of the European Association for Psychotherapy Margaret Rosemary, Gestalt Psychotherapist, GPTI and UKCP registered Jan Roubal, MD PhD, Chair of the Research Committee of the European Association for Gestalt Therapy (EAGT) Prof Andrew Samuels, Prof of Analytical Psychology, University of Essex; Former Chair UKCP Dr Salma Siddique, Director of Counselling, Psychotherapy and Experiential Therapies, School of Education, University of Aberdeen Peter Schulthess, Chair of the Science and Research Committee of European Association for Psychotherapy Dr David Taylor, Training Psychoanalyst, Institute of Psychoanalysis & Visiting Professor, University College London Emma Tickle, Assistant Professor of Counselling University of Nottingham. Helen Thomas, MA MSc UKCP Gestalt Psychotherapist Graham Westwell, Senior Lecturer in Counselling and Psychotherapy, Edge Hill University. Cătălin Zaharia, President of the European Association for Neuro Linguistic Psychotherapy Document prepared by (and correspondence to): Dr Felicitas Rost, President, Society for Psychotherapy Research UK Email: [email protected] Dr Susan McPherson, Senior Lecturer, School of Health and Social Care, University of Essex Email: [email protected] Background According to the Mental Health Foundation, four in ten adults report experiencing depression at some time in their life. The sheer scale of depression in England and Wales should dictate that those charged with revising the 2009 guideline follow the most robust methodology in the most transparent way. In November 2017, the signatories to this position statement wrote to David Haslam, Chair of the National Institute for Health and Care Excellence (NICE), to formally request a second stakeholder consultation of the next revision of the guideline on the Recognition and Management of Depression in Adults, prior to its formal publication. We did this because, along with many other stakeholders, we were extremely concerned about significant flaws in methodology, lack of transparency and several inconsistencies we found in the draft document published in July 2017. We briefed a number of peers and MPs who took seriously our concerns that the document was not fit for purpose. In February 2018, an Early Day Motion was tabled and a number of MPs signed a cross-party letter to NICE asking that they respond to our letter. A meeting took place between the members of this stakeholder coalition and NICE in April 2018, following which, the NICE executive opened a second four-week consultation on the revised draft. Update March 2019: in July 2018, thirty-four MPs and Peers including a former Minister for Health, wrote to Sir Andrew Dillon, CEO of NICE, asking NICE to address our concerns. In October 2018, registered stakeholders received notification that the new guideline would undergo a third revision starting in December 2018. The planned publication date for the guideline is February 2020 with a consultation period from 2nd October to 13th November. The scope for the third revision does not include any of the concerns detailed in this statement. Instead, NICE proposes to update the existing evidence review and to include new work on ‘patient choice’. It is unclear what body of evidence ‘patient choice’ refers to, but NICE have specified that